Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Investment Tools And Research To Help Make You A More Confident And Profitable Trader. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Biora Therapeutics Inc (BIOR)

Biora Therapeutics Inc (BIOR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 9,709
  • Shares Outstanding, K 3,678
  • Annual Sales, $ 4 K
  • Annual Income, $ -124,120 K
  • EBIT $ -68 M
  • EBITDA $ -66 M
  • 60-Month Beta 1.27
  • Price/Sales 2,601.97
  • Price/Cash Flow N/A
  • Price/Book N/A

Options Overview Details

View History
  • Implied Volatility 0.00% ( unch)
  • Historical Volatility 134.46%
  • IV Percentile 0%
  • IV Rank 0.00%
  • IV High 496.33% on 05/24/24
  • IV Low 0.00% on 11/05/24
  • Put/Call Vol Ratio 0.00
  • Today's Volume 11
  • Volume Avg (30-Day) 100
  • Put/Call OI Ratio 0.19
  • Today's Open Interest 2,087
  • Open Int (30-Day) 3,255

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 1 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/24
See More
  • Average Estimate -3.85
  • Number of Estimates 2
  • High Estimate -3.50
  • Low Estimate -4.20
  • Prior Year -7.50
  • Growth Rate Est. (year over year) +48.67%

Price Performance

See More
Period Period Low Period High Performance
1-Month
2.38 +6.72%
on 11/05/24
5.97 -57.45%
on 10/16/24
-2.87 (-53.02%)
since 10/08/24
3-Month
2.38 +6.72%
on 11/05/24
7.10 -64.23%
on 09/03/24
-3.35 (-56.88%)
since 08/08/24
52-Week
2.38 +6.72%
on 11/05/24
19.90 -87.24%
on 02/28/24
-13.26 (-83.92%)
since 11/08/23

Most Recent Stories

More News
Biora Therapeutics to Report Third Quarter 2024 Financial Results and Provide Corporate Update

BIOR : 2.54 (-3.79%)
Biora Therapeutics Announces $3 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules

BIOR : 2.54 (-3.79%)
Biora Therapeutics Shares Progress on Smaller BioJetâ„¢ Clinical Device with Largest Payload of any Ingestible Injectable at the 14th Annual PODD Meeting

BIOR : 2.54 (-3.79%)
Biora Therapeutics to Reveal 00-Size BioJetâ„¢ Device at the 14th Annual Partnership Opportunities in Drug Delivery Meeting

BIOR : 2.54 (-3.79%)
Biora Therapeutics to Present at the 19th Annual Peptide Therapeutics Symposium

BIOR : 2.54 (-3.79%)
Biora Therapeutics Announces Successful Completion of Device Performance Study in Ulcerative Colitis Patients for its Targeted Therapeutics Platform

All Devices Successfully Detected Colon Entry in Patients with Active Ulcerative Colitis...

BIOR : 2.54 (-3.79%)
Biora Therapeutics to Report Second Quarter 2022 Financial Results and Provide Corporate Update

SAN DIEGO, Aug. 08, 2022 (GLOBE NEWSWIRE) -- Biora Therapeutics, Inc. (Nasdaq: BIOR), the biotech company that is reimagining therapeutics, today...

BIOR : 2.54 (-3.79%)
Biora Therapeutics Announces Five Abstracts Accepted at American College of Gastroenterology Annual Scientific Meeting 2022

SAN DIEGO, Aug. 03, 2022 (GLOBE NEWSWIRE) -- Biora Therapeutics, Inc. (Nasdaq: BIOR), the biotech company that is reimagining therapeutics, today...

BIOR : 2.54 (-3.79%)
Biora Therapeutics to Participate in Upcoming BTIG Investment Conference

SAN DIEGO, July 26, 2022 (GLOBE NEWSWIRE) -- Biora Therapeutics, Inc. (Nasdaq: BIOR), the biotech company that is reimagining therapeutics, today...

BIOR : 2.54 (-3.79%)
Biora Therapeutics Shares Preclinical Data on Oral Delivery of Biologics at Controlled Release Society 2022

Demonstrates OBDS Device Performance and Bioavailability in Animal Models...

BIOR : 2.54 (-3.79%)

Business Summary

Biora Therapeutics Inc. is a biotechnology company innovating in the field of oral biotherapeutics for gastrointestinal health and beyond. Biora Therapeutics Inc., formerly known as Progenity Inc., is based in SAN DIEGO.

See More

Key Turning Points

3rd Resistance Point 2.93
2nd Resistance Point 2.81
1st Resistance Point 2.68
Last Price 2.54
1st Support Level 2.42
2nd Support Level 2.30
3rd Support Level 2.17

See More

52-Week High 19.90
Fibonacci 61.8% 13.21
Fibonacci 50% 11.14
Fibonacci 38.2% 9.07
Last Price 2.54
52-Week Low 2.38

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar